Nag. Agri Tech. (531832)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹18.9 |
| Market Cap | ₹18.9 Cr |
| P/E Ratio | 504.44 |
| ROCE | -1.34% |
| ROE | 1.42% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹34.59 — ₹55.5 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹7.16 |
Strengths
- Positive book value of ₹7.16 per share offers some tangible asset backing, though price is far above it.
- Latest quarter sales of ₹10 Cr indicate some ongoing operating activity.
- Small market cap of ₹19 Cr means a genuine turnaround could move the needle if operations improve.
- Zero reported dividend means no cash leakage, but that is not a virtue when returns are so poor.
Concerns
- P/E of 504.44 with zero sales and profit growth means an extreme valuation for a stagnant business.
- ROE of 1.42% and negative ROCE of -1.34% show the company is not creating value for shareholders.
- Piotroski F-Score of 2/9 signals weak financial health and possible operational distress.
- Current price of ₹18.90 is inconsistent with the stated 52-week range of ₹34.59–64.28, raising serious data reliability concerns.
AI Analysis
At first glance, Nag Agri Tech has the surface of a small Indian agricultural business, but after turning the numbers over I see little to like. Graham taught me that price is what you pay and value is what you get. Here I would be paying ₹18.90 for a company earning almost nothing. A P/E of 504.44 with sales and profit growth at 0.00% tells me I am buying a stagnant earnings stream at an absurd multiple. The underlying returns are worse: ROCE is negative at -1.34% and ROE is barely 1.42%. A business that cannot earn more than a fixed deposit on shareholder equity has no durable economic moat. Agricultural commodities give it little pricing power, no apparent brand, and no clear edge. Book value is ₹7.16, so at P/B of 2.64 the market already asks me to pay a big premium for weak returns. The Piotroski score of 2/9 is a serious red flag—this is near the bottom of the financial-health scale. There is no dividend to compensate me while I wait. Worse, the stated 52-week range of ₹34.59–64.28 cannot be squared with a current price of ₹18.90. If the data is wrong, I cannot trust the baseline; if it is right, this is a stock that has collapsed and still looks overvalued. Either way, there is no margin of safety. Negative ROCE, zero growth, and a 2/9 F-score are exactly the warning signs Buffett and Graham told us to avoid. I would not want to own this with real money. The valuation must fall to a meaningful discount to book, and operations must show sustained positive earnings, before I would spend another minute. For now, this is a pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer